Navigation Links
The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines

The Indian Government has recently approved human volunteer trials for the country's second preventive// vaccine against HIV, the virus that leads to AIDS. A vaccine for the developing world, where anti-retroviral drugs are out of reach for millions of HIV-infected people, would be the ultimate prize in the fight against AIDS. But efforts to find one have been hampered by the virus's ability to mutate.

After South Africa , India has the second-largest number of people living with the killer virus .In its efforts to further prevent the spread of the deadly disease India started human trials on its first preventive vaccine in February this year, since the first vaccine has been making good progress , the government has received all clearances for the human trials of a second vaccine. Scientists say they need to test different vaccines on the same or separate strains of a virus to develop the most effective antibodies.

In February, researchers began trials on 34 healthy adult volunteers for tgAAC09 vaccine that targets HIV subtype C, widely prevalent in India, South Africa and China. The trials for the second vaccine -- called the Modified Vaccinia Ankara (MVA) -- will be carried out at the Tuberculosis Research Centre in the southern city of Madras. The MVA will also target HIV subtype C.

During the first phase of such trials, vaccines are usually tested on healthy volunteers who are given a controlled dosage of the HIV subtype C virus to create resistance after a consent id obtained from the volunteer due to the risk of possible HIV infection.

In the second phase, the vaccine is given to a smaller group of high-risk individuals -- sex workers, drug users and homosexuals -- to check for the efficacy of the dosage. They are not asked to alter their regular lifestyles. If the vaccine is seen to work on both groups, it is then given to a larger group of up to 1,000 people. Most importantly at every stage of the trial all volunteer s have to be HIV-negative when they sign up.

In the fourth and last phase -- if the results of earlier phases are found to be satisfactory -- marketing of the vaccine is done and post-marketing surveillance carried out. Experts say it takes years for a successful vaccine to be developed.

The International AIDS Vaccine Initiative (IAVI), which coordinates the global search for a vaccine, says India is important because of its advanced biomedical research facilities and strong pharmaceutical industry which has developed cheap and effective AIDS drugs that are exported across the globe.
'"/>




Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... 12, 2017 , ... In the United States, single-family home ... states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is ... low property-tax rates, which contributes to the relatively lower cost of living in ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: